Morgan Stanley Absci Corp Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Absci Corp stock. As of the latest transaction made, Morgan Stanley holds 132,379 shares of ABSI stock, worth $557,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,379

Previous 48,270 174.25%

Holding current value

$557,315

Previous $202,000 271.78%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.41 - $5.74 $286,811 - $482,785	84,109 Added 174.25%	132,379 $751,000
Q4 2023 Feb 13, 2024	BUY	$1.15 - $4.79 $868 - $3,616	755 Added 1.59%	48,270 $202,000
Q3 2023 Nov 15, 2023	SELL	$1.28 - $2.41 $60,971 - $114,797	-47,634 Reduced 50.06%	47,515 $62,000
Q2 2023 Aug 14, 2023	SELL	$1.17 - $2.03 $25,740 - $44,659	-22,000 Reduced 18.78%	95,149 $144,000
Q1 2023 May 15, 2023	BUY	$1.58 - $3.41 $14,016 - $30,250	8,871 Added 8.19%	117,149 $205,000

Q4 2022 Feb 14, 2023	BUY	$2.0 - $3.58 $37,412 - $66,967	18,706 Added 20.88%	108,278 $227,000
Q3 2022 Nov 14, 2022	BUY	$2.95 - $4.83 $107,648 - $176,251	36,491 Added 68.75%	89,572 $280,000
Q2 2022 Oct 27, 2022	BUY	$3.13 - $8.83 $89,114 - $251,398	28,471 Added 115.69%	53,081 $176,000
Q2 2022 Aug 15, 2022	BUY	$3.13 - $8.83 $89,114 - $251,398	28,471 Added 115.69%	53,081 $176,000
Q1 2022 Oct 27, 2022	SELL	$5.87 - $9.46 $167,124 - $269,335	-28,471 Reduced 53.64%	24,610 $208,000
Q1 2022 May 13, 2022	BUY	$5.87 - $9.46 $42,933 - $69,190	7,314 Added 42.29%	24,610 $208,000
Q4 2021 Feb 14, 2022	BUY	$7.88 - $18.03 $113,322 - $259,289	14,381 Added 493.34%	17,296 $141,000
Q3 2021 Nov 15, 2021	BUY	$10.37 - $30.29 $30,228 - $88,295	2,915 New	2,915 $34,000

Others Institutions Holding ABSI

# of Institutions

119

Shares Held

45.7M

Call Options Held

426K

Put Options Held

123K

View Full List

About Absci Corp

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $391M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

More about ABSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account